Unveiling the Mechanism of Liangxue Siwu Decoction in Treating Rosacea Through Network Pharmacology and in-vitro Experimental Validation
Yun Zhong,Yufei Zhao,Xin Meng,Fan Wang,Lei Zhou
DOI: https://doi.org/10.2147/jir.s471097
IF: 4.5
2024-08-29
Journal of Inflammation Research
Abstract:Yun Zhong, 1– 3 Yufei Zhao, 4 Xin Meng, 2 Fan Wang, 2 Lei Zhou 1 1 Department of Dermatology, the Third Affiliated Hospital, Sun Yat-Sen University, Guangzhou, People's Republic of China; 2 Department of Dermatology, Xiangya Hospital, Central South University, Changsha, People's Republic of China; 3 Department of Dermatology, Nanfang Hospital, Southern Medical University, Guangzhou, People's Republic of China; 4 Department of Gastrointestinal Surgery, Laboratory of Surgery, the Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, People's Republic of China Correspondence: Lei Zhou, Department of Dermatology, the Third Affiliated Hospital, Sun Yat-sen University, 600 Tianhe Road, Tianhe District, Guangzhou, Guangdong, 510630, People's Republic of China, Tel +020-85253333, Fax +020-85253336, Email Background: Rosacea, a recurring dermatological disorder, demands effective therapeutic approaches. Traditional Chinese medicine, particularly Liangxue Siwu Decoction (LXSWD), has shown promise in managing inflammatory skin diseases, such as rosacea. This study focuses on uncovering LXSWD's specific effects on the inflammatory symptoms of rosacea. Objective: Our research investigates LXSWD's therapeutic effectiveness in rosacea treatment and delves into its underlying mechanisms. Methods: Network pharmacology was utilized to identify LXSWD's key components and their targets in rosacea management, which were then validated by molecular docking. An in vivo rosacea-like model in LL-37-induced mice was developed, subdividing them into control, model, and LXSWD groups. The LXSWD group received oral administration (25.0 g/kg/day) for six days before model induction. Post-treatment evaluations included skin tissue analyses to verify our network pharmacology predictions. Results: Key active ingredients in LXSWD, such as quercetin, kaempferol, and luteolin, were identified alongside central target proteins like TNF and MMPs. Our molecular docking study confirmed the interactions between these ingredients and targets. Analyses through GO and KEGG pathways indicated LXSWD's role in mitigating inflammation, particularly influencing the TNF and IL-17 pathways. LXSWD treatment in vivo markedly alleviated LL-37-induced symptoms in mice, showing a marked reduction in inflammatory cytokines ( p < 0.05) and modulation of crucial genes ( p < 0.05). These results, supported by immunofluorescence analysis and Western blot, underline the modulatory effects of LXSWD on MMPs, offering significant protection against rosacea's inflammation alterations ( p < 0.05). Conclusion: Integrating network pharmacology, molecular docking, and in vivo experiments, this study elucidates LXSWD's potential mechanisms in rosacea treatment. It offers a novel theoretical framework for its clinical use in managing rosacea. Keywords: Liangxue siwu decoction, molecular docking, network pharmacology, rosacea, skin inflammation Rosacea is a chronic skin disorder that primarily affects the face, characterized by pronounced redness, papules, and pustules. This condition is often mistaken for other skin disorders such as acne, dermatitis, or allergic reactions, and it predominantly occurs in individuals with lighter skin tones. 1,2 Nonetheless, it can occur in people of all skin types. 3 The development of rosacea is believed to result from a combination of genetic and environmental factors. 4,5 Rosacea's onset is often linked to an overactive immune reaction, activated by a variety of stimuli. These include exposure to certain bacteria, mites, or specific infection that cause facial blood vessels to widen. 6,7 Additionally, several external factors, such as the consumption of hot beverages, spicy foods, alcohol, exposure to extreme temperatures, and emotional stress, can exacerbate rosacea symptoms by increasing blood flow to the skin or sustaining inflammation. While rosacea is not a life-endangering condition, it can lead to considerable emotional and psychological discomfort, causing affected individuals to feel self-conscious about their appearance. 8–10 For centuries, Traditional Chinese Medicine (TCM) has offered effective treatments for a variety of health issues, including skin conditions such as rosacea. 11–13 One of the notable treatments is the Liangxue Siwu Decoction (LXSWD), known for its potential therapeutic effects. According to ancient TCM principles, LXSWD is formulated to "cool the blood" and "nourish the yin", addressing the underlying imbalances believed to contribute to the development of rosacea. LXSWD's application is not limited to rosac -Abstract Truncated-
immunology